Lesson plan
BioAmber
BioAmber Inc. was a Delaware (USA) registered Canadian sustainable chemicals company that was headquartered in Montreal, Quebec, Canada. Its proprietary technology platform combined industrial biotechnology and chemical catalysis to convert renewable feedstock into building block chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products. BioAmber was listed on the New York Stock Exchange between May 2013 and February 2018, under the symbol BIOA. It was also listed on the Toronto Stock Exchange under the same symbol. Bioamber officially ceased operations in August 2018', all directors of the company resigned & PriceWaterhouseCoopers proceeded forward in court authorized control of the company's fate. BioAmber no longer has any offices or facilities in Canada or the United States after completion of a CCAA Insolvency / USA Chapter 15 foreign arrangement, in which the company was liquidated & all major assets were sold off. On November 22, 2019, FINRA, (https://www.finra.org/about) the USA Financial Regulatory Authority officially suspended the company's CUSIP registration thus finalizing the outcome for Bioamber & delisting it from all tradeable stock exchanges.
Article summary
BioAmber Inc. was a Delaware (USA) registered Canadian sustainable chemicals company that was headquartered in Montreal, Quebec, Canada. Its proprietary technology platform combined industrial biotechnology and chemical catalysis to convert renewable feedstock into building block chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products. BioAmber was listed on the New York Stock Exchange between May 2013 and February 2018, under the symbol BIOA. It was also listed on the Toronto Stock Exchange under the same symbol. Bioamber officially ceased operations in August 2018', all directors of the company resigned & PriceWaterhouseCoopers proceeded forward in court authorized control of the company's fate. BioAmber no longer has any offices or facilities in Canada or the United States after completion of a CCAA Insolvency / USA Chapter 15 foreign arrangement, in which the company was liquidated & all major assets were sold off. On November 22, 2019, FINRA, (https://www.finra.org/about) the USA Financial Regulatory Authority officially suspended the company's CUSIP registration thus finalizing the outcome for Bioamber & delisting it from all tradeable stock exchanges.
Key claims
- date of establishment: 2008 — source: Wikipedia, revision 1359344339, retrieved 2026-10-20 · confidence 0.95
- publication date: 2013 — source: Wikipedia, revision 1359344339, retrieved 2026-10-20 · confidence 0.95
- publication date: 2012 — source: Wikipedia, revision 1359344339, retrieved 2026-10-20 · confidence 0.95
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- The record states that the date of establishment is "2008". What evidence would count against this claim?
- The record states that the publication date is "2013". What evidence would count against this claim?
- The record states that the publication date is "2012". What evidence would count against this claim?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
- Wikipedia, “BioAmber”, revision 1359344339, retrieved 2026-10-20 https://en.wikipedia.org/w/index.php?oldid=1359344339
Key claims and bibliography are generated from the same tracked claims and sources as the article page.